320 related articles for article (PubMed ID: 19627484)
1. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
[TBL] [Abstract][Full Text] [Related]
2. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
3. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
4. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
[TBL] [Abstract][Full Text] [Related]
5. [Effect of neferine on adriamycin-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance].
Ai XH; Tang XQ; Liu YP; Liu HQ; Dong L
Ai Zheng; 2007 Apr; 26(4):357-60. PubMed ID: 17430651
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes.
Hu Y; Pang E; Lai PB; Squire JA; MacGregor PF; Beheshti B; Albert M; Leung TW; Wong N
Int J Oncol; 2004 Nov; 25(5):1357-64. PubMed ID: 15492826
[TBL] [Abstract][Full Text] [Related]
7. Gene expressions associated with chemosensitivity in human hepatoma cells.
Hoshida Y; Moriyama M; Otsuka M; Kato N; Taniguchi H; Shiratori Y; Seki N; Omata M
Hepatogastroenterology; 2007 Mar; 54(74):489-92. PubMed ID: 17523305
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
Yan F; Wang XM; Pan C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531
[TBL] [Abstract][Full Text] [Related]
10. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
12. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
13. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
14. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects and in vitro reversal of multidrug resistance by therapeutic ultrasound in human hepatocarcinoma cell line (HepG2).
Shao ZY; Zhai BJ; Zhao CL; Hu K; Shen DM; Wu F
Ultrasonics; 2008 Aug; 48(4):297-302. PubMed ID: 18199465
[TBL] [Abstract][Full Text] [Related]
16. Agaricus blazei Murill enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells by NFκB-mediated increase of intracellular doxorubicin accumulation.
Lee JS; Hong EK
Int J Oncol; 2011 Feb; 38(2):401-8. PubMed ID: 21132265
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor.
Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S
Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652
[TBL] [Abstract][Full Text] [Related]
18. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma.
Al-Rawashdeh FY; Scriven P; Cameron IC; Vergani PV; Wyld L
Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1099-105. PubMed ID: 20177386
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
Zhang H; Ozaki I; Mizuta T; Matsuhashi S; Yoshimura T; Hisatomi A; Tadano J; Sakai T; Yamamoto K
Cancer; 2002 Aug; 95(4):896-906. PubMed ID: 12209735
[TBL] [Abstract][Full Text] [Related]
20. High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: the role of P-glycoprotein and mitogen-activated protein kinase p44/42 pathway.
Manov I; Bashenko Y; Eliaz-Wolkowicz A; Mizrahi M; Liran O; Iancu TC
J Pharmacol Exp Ther; 2007 Sep; 322(3):1013-22. PubMed ID: 17526808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]